Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) EBIT Margin: 2010-2025

Historic EBIT Margin for Mesa Laboratories (MLAB) over the last 16 years, with Sep 2025 value amounting to 7.78%.

  • Mesa Laboratories' EBIT Margin rose 171.00% to 7.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.13%, marking a year-over-year increase of 12097.00%. This contributed to the annual value of 6.78% for FY2025, which is 13263.00% up from last year.
  • Mesa Laboratories' EBIT Margin amounted to 7.78% in Q3 2025, which was up 51.15% from 5.15% recorded in Q2 2025.
  • Over the past 5 years, Mesa Laboratories' EBIT Margin peaked at 11.72% during Q3 2021, and registered a low of -460.55% during Q1 2024.
  • Its 3-year average for EBIT Margin is -38.28%, with a median of 2.36% in 2025.
  • As far as peak fluctuations go, Mesa Laboratories' EBIT Margin slumped by 46,148bps in 2024, and later spiked by 46,292bps in 2025.
  • Over the past 5 years, Mesa Laboratories' EBIT Margin (Quarterly) stood at -4.59% in 2021, then surged by 1,086bps to 6.27% in 2022, then plummeted by 639bps to -0.13% in 2023, then skyrocketed by 932bps to 9.20% in 2024, then skyrocketed by 171bps to 7.78% in 2025.
  • Its last three reported values are 7.78% in Q3 2025, 5.15% for Q2 2025, and 2.36% during Q1 2025.